| Income Statement | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Total revenues | 18,510 | 20,437 | 20,490 | |
| Selling, general and administrative | 23,590 | 19,475 | 24,129 | |
| Research and development | 760 | 949 | 928 | |
| Cost of product sales | 1,750 | 2,065 | 1,981 | |
| Total costs and expenses | 26,100 | 22,489 | 27,038 | |
| Loss from operations | -7,590 | -2,052 | -6,548 | |
| Unrealized loss on fair value of derivative features | -8,760 | - | - | |
| Interest income | 621 | 913 | 809 | |
| Interest expense | 4,887 | 5,294 | 4,947 | |
| Foreign currency (gain) loss | - | - | 5 | |
| Unrealized loss on fair value of warrants | 1,800 | -6,900 | -3,100 | |
| Net loss | -22,416 | 467 | -7,581 | |
| Less undistributed earnings to participating shareholders | - | 74 | - | |
| Net income (loss) - basic | - | 393 | -7,581 | |
| Add: unrealized gain on fair value of warrants | - | - | 3,100 | |
| Net (loss) income - diluted | - | - | -10,681 | |
| Basic eps | -1.92 | 0 | -0.05 | |
| Diluted eps | -1.92 | 0 | -0.07 | |
| Basic average shares | 11,667,531 | 174,328,570 | 147,455,374 | |
| Diluted average shares | 11,667,531 | 174,369,875 | 150,698,374 | |
null (OPTN)
null (OPTN)